ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near Warszawa, Mazowieckie, POL:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Warsaw, Poland and 209 other locations

The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS).

Enrolling
Small Cell Lung Cancer
Limited Stage Small Cell Lung Cancer
Drug: Placebo
Drug: Tarlatamab

Phase 3

Amgen
Amgen

Warszawa, Poland and 124 other locations

KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Sotorasib
Drug: Divarasib

Phase 3

Roche
Roche

Warszawa, Poland and 61 other locations

protein 4 \[CTLA4\] antibody \[another investigational medicinal product\]) in patients with advanced or metastasized non-small cell lung ca...

Enrolling
Non-Small Cell Lung Cancer
Biological: BNT116
Drug: Carboplatin

Phase 1

BioNTech
BioNTech

Warsaw, Poland and 37 other locations

The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...

Active, not recruiting
Relapsed/Refractory Small Cell Lung Cancer
Drug: Tarlatamab

Phase 2

Amgen
Amgen

Otwock, Poland and 79 other locations

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, imp...

Active, not recruiting
Neoplasms by Site
Neoplasms, Nerve Tissue
Drug: Carboplatin
Drug: Nab-Paclitaxel

Phase 3

Roche
Roche

Warszawa, Poland and 87 other locations

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...

Active, not recruiting
Non-small Cell Lung Cancer
Lung Cancer
Drug: Bevacizumab
Drug: Carboplatin

Phase 3

Prestige Biopharma

Warszawa, Poland and 17 other locations

the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non-Small Cell Lung...

Active, not recruiting
Metastatic Non-Small Cell Lung Cancer (NSCLC)
Drug: AZD2936
Drug: Pemetrexed

Phase 1

AstraZeneca
AstraZeneca

Warszawa, Poland and 41 other locations

overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: Nab-Paclitaxel
Drug: Cisplatin

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Warszawa, Poland and 126 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 238 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems